Stay updated on Dupilumab in Bullous Pemphigoid Adults Clinical Trial
Sign up to get notified when there's something new on the Dupilumab in Bullous Pemphigoid Adults Clinical Trial page.

Latest updates to the Dupilumab in Bullous Pemphigoid Adults Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedUpdated date-related labels and newer timestamps were added; older date references and an Expanded Access note were removed. Overall, the changes update timing information without altering core content.SummaryDifference0.9%

- Check21 days agoNo Change Detected
- Check28 days agoChange DetectedMajor update: page now includes a government funding status notice and indicates version 3.2.0, replacing the previous 3.1.0.SummaryDifference3%

- Check35 days agoChange DetectedVersion bump from v3.0.2 to v3.1.0; no other content changes detected.SummaryDifference0.1%

- Check50 days agoChange DetectedThe page version is updated from v3.0.1 to v3.0.2. The 'Back to Top' element has been removed.SummaryDifference0.2%

- Check57 days agoChange DetectedThe web page has been updated from version 3.0.0 to 3.0.1, indicating a revision in the content. There are no significant changes to core content or important information.SummaryDifference0.2%

- Check64 days agoChange DetectedThe web page has undergone significant updates, including the addition of a facility name and specific locations related to the study on bullous pemphigoid, while also removing several previous location references.SummaryDifference5%

Stay in the know with updates to Dupilumab in Bullous Pemphigoid Adults Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dupilumab in Bullous Pemphigoid Adults Clinical Trial page.